These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20951760)

  • 1. Mapping the eosinophil cationic protein antimicrobial activity by chemical and enzymatic cleavage.
    Sánchez D; Moussaoui M; Carreras E; Torrent M; Nogués V; Boix E
    Biochimie; 2011 Feb; 93(2):331-8. PubMed ID: 20951760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment.
    Torrent M; de la Torre BG; Nogués VM; Andreu D; Boix E
    Biochem J; 2009 Jul; 421(3):425-34. PubMed ID: 19450231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of unique basic residues in cytotoxic, antibacterial and antiparasitic activities of human eosinophil cationic protein.
    Singh A; Batra JK
    Biol Chem; 2011 Apr; 392(4):337-46. PubMed ID: 21303303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through its RNase active site.
    Torrent M; Nogués MV; Boix E
    J Mol Recognit; 2011; 24(1):90-100. PubMed ID: 20213669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both aromatic and cationic residues contribute to the membrane-lytic and bactericidal activity of eosinophil cationic protein.
    Carreras E; Boix E; Rosenberg HF; Cuchillo CM; Nogués MV
    Biochemistry; 2003 Jun; 42(22):6636-44. PubMed ID: 12779318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards the rational design of antimicrobial proteins: single point mutations can switch on bactericidal and agglutinating activities on the RNase A superfamily lineage.
    Pulido D; Moussaoui M; Nogués MV; Torrent M; Boix E
    FEBS J; 2013 Nov; 280(22):5841-52. PubMed ID: 23992292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophil cationic protein high-affinity binding to bacteria-wall lipopolysaccharides and peptidoglycans.
    Torrent M; Navarro S; Moussaoui M; Nogués MV; Boix E
    Biochemistry; 2008 Mar; 47(11):3544-55. PubMed ID: 18293932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of human RNase 3 and RNase 7 bactericidal action at the Gram-negative and Gram-positive bacterial cell wall.
    Torrent M; Badia M; Moussaoui M; Sanchez D; Nogués MV; Boix E
    FEBS J; 2010 Apr; 277(7):1713-25. PubMed ID: 20180804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophil cationic protein aggregation: identification of an N-terminus amyloid prone region.
    Torrent M; Odorizzi F; Nogués MV; Boix E
    Biomacromolecules; 2010 Aug; 11(8):1983-90. PubMed ID: 20690710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-binding and antimicrobial properties of synthetic peptides of bovine apolipoprotein A-II.
    Motizuki M; Itoh T; Satoh T; Yokota S; Yamada M; Shimamura S; Samejima T; Tsurugi K
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):215-21. PubMed ID: 10432319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sulfate-binding site structure of the human eosinophil cationic protein as revealed by a new crystal form.
    Boix E; Pulido D; Moussaoui M; Nogués MV; Russi S
    J Struct Biol; 2012 Jul; 179(1):1-9. PubMed ID: 22579681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A one-enzyme strategy to release an antimicrobial peptide from the LFampin-domain of bovine lactoferrin.
    Bolscher JG; van der Kraan MI; Nazmi K; Kalay H; Grün CH; Van't Hof W; Veerman EC; Nieuw Amerongen AV
    Peptides; 2006 Jan; 27(1):1-9. PubMed ID: 16087276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refining the eosinophil cationic protein antibacterial pharmacophore by rational structure minimization.
    Torrent M; Pulido D; de la Torre BG; García-Mayoral MF; Nogués MV; Bruix M; Andreu D; Boix E
    J Med Chem; 2011 Jul; 54(14):5237-44. PubMed ID: 21696142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural determinants of the eosinophil cationic protein antimicrobial activity.
    Boix E; Salazar VA; Torrent M; Pulido D; Nogués MV; Moussaoui M
    Biol Chem; 2012 Aug; 393(8):801-15. PubMed ID: 22944682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional crystal structure of human eosinophil cationic protein (RNase 3) at 1.75 A resolution.
    Mallorquí-Fernández G; Pous J; Peracaula R; Aymamí J; Maeda T; Tada H; Yamada H; Seno M; de Llorens R; Gomis-Rüth FX; Coll M
    J Mol Biol; 2000 Jul; 300(5):1297-307. PubMed ID: 10903870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an active site residue of the R1 subunit of ribonucleotide reductase from Escherichia coli: characterization of substrate-induced polypeptide cleavage by C225SR1.
    van der Donk WA; Zeng C; Biemann K; Stubbe J; Hanlon A; Kyte J
    Biochemistry; 1996 Aug; 35(31):10058-67. PubMed ID: 8756468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein post-translational modification in host defense: the antimicrobial mechanism of action of human eosinophil cationic protein native forms.
    Salazar VA; Rubin J; Moussaoui M; Pulido D; Nogués MV; Venge P; Boix E
    FEBS J; 2014 Dec; 281(24):5432-46. PubMed ID: 25271100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial peptides derived from goose egg white lysozyme.
    Thammasirirak S; Pukcothanung Y; Preecharram S; Daduang S; Patramanon R; Fukamizo T; Araki T
    Comp Biochem Physiol C Toxicol Pharmacol; 2010 Jan; 151(1):84-91. PubMed ID: 19737628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topography studies on the membrane interaction mechanism of the eosinophil cationic protein.
    Torrent M; Cuyás E; Carreras E; Navarro S; López O; de la Maza A; Nogués MV; Reshetnyak YK; Boix E
    Biochemistry; 2007 Jan; 46(3):720-33. PubMed ID: 17223693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An insertion in loop L7 of human eosinophil-derived neurotoxin is crucial for its antiviral activity.
    Sikriwal D; Seth D; Parveen S; Malik A; Broor S; Batra JK
    J Cell Biochem; 2012 Oct; 113(10):3104-12. PubMed ID: 22581709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.